Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10349125rdf:typepubmed:Citationlld:pubmed
pubmed-article:10349125lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:10349125lifeskim:mentionsumls-concept:C0330390lld:lifeskim
pubmed-article:10349125lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:10349125lifeskim:mentionsumls-concept:C0521428lld:lifeskim
pubmed-article:10349125lifeskim:mentionsumls-concept:C0000413lld:lifeskim
pubmed-article:10349125lifeskim:mentionsumls-concept:C1157302lld:lifeskim
pubmed-article:10349125pubmed:issue1lld:pubmed
pubmed-article:10349125pubmed:dateCreated1999-8-19lld:pubmed
pubmed-article:10349125pubmed:abstractTextAdrenarche is the maturational increase of adrenal androgens that takes place in 6-8 year old children. In order to study the role of 3 beta HSD in the regulation of the synthesis of human adrenal androgens, the abundance of 3 beta HSD mRNA (Dot Blot and semiquantitative RT-PCR) was measured in 11 human prepubertal and early pubertal adrenal tissues. Subjects were divided in 2 age groups (Gr): Gr1, < 8 years (y) old (n = 6, range 0.1-2.5) and Gr2, > or = 8 y old (n = 5, range 8.0-13.0). Tissue from one adrenal tumor with Cushing's syndrome (TSC) and 2 virilizing adrenal tumors (TV), as well as adrenal cells prepared from the TSC and from 1 TV were also studied. They were maintained in culture for 3 days in basal conditions (BC) and under ACTH and IGF-1 stimulation. mRNA in Gr1 was higher than in Gr2 (Dot blot: 4.65 +/- 2.70 and 0.28 +/- 0.27 AU, p = 0.006; RT-PCR: 21.5 +/- 12.5 and 6.77 +/- 3.78 AU, p = 0.039, respectively). 3 beta HSD mRNA in TSC (8.74 +/- 1.74) was higher than in the 2 TVs (0.47 +/- 0.02 and 0.87 +/- 0.08) p = 0.001. In TSC cells, basal mRNA (0.82 +/- 0.10) decreased under ACTH (0.55 +/- 0.06), p = 0.005, and increased under IGF-1 (2.36 +/- 0.07), p = 0.006. No changes were observed in TV cells. On day 3, TV cells in BC secreted 1170.0 +/- 210.0 and 335.0 +/- 29.0 pmol/10(6) cells in 24 hs of DHEAS and androstenedione, while TSC cells secreted 17.1 +/- 3.5 and 73.7 +/- 11.7, respectively. Values increased under ACTH in TV cells (2006.0 +/- 360.0 and 525.0 +/- 76.0) and in TSC cells (29.8 +/- 5.4 and 366.8 +/- 129) p < 0.05, but they decreased under IGF-1 only in TSC cells (7.9 +/- 2.4 and 43.7 +/- 6.1) p < 0.05. These data support the hypothesis that human adrenarche could be secondary to a decrease of 3 beta HSD mRNA. Our finding that when 3 beta HSD mRNA decreases androgen secretion increases (ACTH) and when 3 beta HSD mRNA increases androgen secretion decreases (IGF-1), strongly suggests that 3 beta HSD has a modulatory role in adrenal androgen steroidogenesis.lld:pubmed
pubmed-article:10349125pubmed:languagespalld:pubmed
pubmed-article:10349125pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10349125pubmed:citationSubsetIMlld:pubmed
pubmed-article:10349125pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10349125pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10349125pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10349125pubmed:statusMEDLINElld:pubmed
pubmed-article:10349125pubmed:issn0025-7680lld:pubmed
pubmed-article:10349125pubmed:authorpubmed-author:DardikIIlld:pubmed
pubmed-article:10349125pubmed:authorpubmed-author:RivarolaMMlld:pubmed
pubmed-article:10349125pubmed:authorpubmed-author:BelgoroskyAAlld:pubmed
pubmed-article:10349125pubmed:authorpubmed-author:BerenszteinEElld:pubmed
pubmed-article:10349125pubmed:authorpubmed-author:SaracoNNlld:pubmed
pubmed-article:10349125pubmed:issnTypePrintlld:pubmed
pubmed-article:10349125pubmed:volume59lld:pubmed
pubmed-article:10349125pubmed:ownerNLMlld:pubmed
pubmed-article:10349125pubmed:authorsCompleteYlld:pubmed
pubmed-article:10349125pubmed:pagination79-82lld:pubmed
pubmed-article:10349125pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:meshHeadingpubmed-meshheading:10349125...lld:pubmed
pubmed-article:10349125pubmed:year1999lld:pubmed
pubmed-article:10349125pubmed:articleTitle[Role of 3 beta hydroxysteroid dehydrogenase (3 beta HSD) in human adrenal androgen synthesis].lld:pubmed
pubmed-article:10349125pubmed:affiliationLaboratorio de Investigación, Hospital de Pediatría Garrahan, Buenos Aires, Argentina.lld:pubmed
pubmed-article:10349125pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10349125pubmed:publicationTypeEnglish Abstractlld:pubmed